DORMANT studio
localhost:3000

Opportunity radar

4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05

Showing50 of 77,862
Free-text
CPC starts with (comma sep)
Min fwd citations
Clear
Patent #TitleAssetsIssuedExpiresFwd citesScore
12576028Pharmaceutical or nutraceutical self-emulsifying solid dispersion composition🖼🧊📄§2026-03-172043-01-18031
12576029Noncompetitive receptor-targeted vaccine delivery to plasmacytoid dendritic cells🖼🧊📄§2026-03-172043-07-12031
12576035Polymeric implants with high drug loading and long-acting drug release and methods of making the same🖼🧊📄§2026-03-172040-01-31031
12576039Lipid-polymer compositions and methods of use🖼🧊📄§2026-03-172041-05-18031
12576038Composition, lipid particle manufacturing kit, substance delivery method, and detection method🖼🧊📄§2026-03-172041-09-10031
12576044Treatment of Alzheimer's disease🖼🧊📄§2026-03-172043-05-03031
12576046Aqueous paediatric retinol formulations🖼🧊📄§2026-03-172039-11-26031
12576048Anti-cancer activity of adamantane derivatives🖼🧊📄§2026-03-172039-12-05031
12576047Telomerase activating compounds for use in fertility and related applications🖼🧊📄§2026-03-172043-08-25031
12576050Dosage regime🖼🧊📄§2026-03-172039-10-17031
12576051Methods and composition for treating respiratory obstructive diseases🖼🧊📄§2026-03-172040-07-30031
12576055Disease detection and treatment based on trimethyl-lysine levels🖼🧊📄§2026-03-172039-02-01031
12576054Vigabatrin liquid pharmaceutical composition🖼🧊📄§2026-03-172043-05-16031
12576056Amino acid-containing granules🖼🧊📄§2026-03-172040-09-18031
12576059Methods and compositions for treatment of inflammatory disease🖼🧊📄§2026-03-172044-03-21031
12576061Agent for inducing regression of triglyceride deposit atherosclerosis🖼🧊📄§2026-03-172041-03-05031
12576063Implantable drug delivery devices for localized drug delivery🖼🧊📄§2026-03-172040-12-18031
12576066Methods and compositions for treatment of mydriasis🖼🧊📄§2026-03-172045-01-17031
12576065Enhancing autophagy or increasing longevity by administration of urolithins🖼🧊📄§2026-03-172045-04-04031
12576064Urolithin gummy (pectin) formulations🖼🧊📄§2026-03-172045-08-27031
12576075Combination therapies for treating cancer🖼🧊📄§2026-03-172039-10-30031
12576071Pharmaceutical compositions🖼🧊📄§2026-03-172044-12-02031
12576072Liquid pharmaceutical composition🖼🧊📄§2026-03-172041-12-03031
12575549Application of TPK as a target in Alzheimer's disease🖼🧊📄§2026-03-172042-02-02031
12571800Means and methods for treating angiogenesis-related diseases🖼🧊📄§2026-03-102042-10-14031
12570966Mutated PIGGYBAC® transposase🖼🧊📄§2026-03-102039-12-09031
12570735Compositions and methods for treating inflammasome related diseases or conditions🖼🧊📄§2026-03-102039-07-03031
12570605Indole compounds, and preparation methods, and uses thereof🖼🧊📄§2026-03-102042-09-02031
12570606Myeloperoxidase imaging agents🖼🧊📄§2026-03-102042-04-29031
12570687Triterpenoid compounds, pharmaceutical compositions thereof, and their use for treating a nuclear receptor subfamily 4 group a member 1-mediated disease🖼🧊📄§2026-03-102040-09-14031
12570689Purification of GLP-1 analogues🖼🧊📄§2026-03-102040-02-05031
12570694Peptides and pharmaceutical, nutraceutical or veterinary compositions for hair loss prevention and/or treatment🖼🧊📄§2026-03-102042-09-14031
12570708Recombinant proteins and their therapeutic uses🖼🧊📄§2026-03-102044-07-02031
12570709Self-assembling peptide amphiphiles displaying a transforming growth factor beta 1 (TGF-ß1) mimetic epitope🖼🧊📄§2026-03-102042-07-28031
12570759Polypeptides🖼🧊📄§2026-03-102039-12-17031
12570753Combination therapies with anti CD40 antibodies🖼🧊📄§2026-03-102043-12-13031
12569570Compositions and methods for targeted RNA delivery🖼🧊📄§2026-03-102044-01-23031
12569561Double stranded oligonucleotide construct comprising androgen receptor specific sequence, and composition for preventing hair loss and promoting hair growth comprising same🖼🧊📄§2026-03-102039-11-18031
12569431Immunostimulatory method🖼🧊📄§2026-03-102043-10-10031
12569450Nanoparticles for medical and diagnostic applications🖼🧊📄§2026-03-102040-11-09031
12569481Methods of treatment for gastrointestinal motility disorders🖼🧊📄§2026-03-102041-06-11031
12569506Methods of treating osteonecrosis with LLP2A-bisphosphonate compounds🖼🧊📄§2026-03-102040-08-18031
12568993Shelf-stable nitrogenous organic acid compositions🖼🧊📄§2026-03-102038-10-18031
12573519Materials and processes for generating radioisotopes🖼🧊📄§2026-03-102045-05-21031
12573050Systems and methods for platform agnostic whole body image segmentation🖼🧊📄§2026-03-102044-01-31031
12570961Methods and compositions for T-cell coculture potency assays and use with cell therapy products🖼🧊📄§2026-03-102042-03-25031
12570973Compositions and methods for inhibiting intermediate filament tetramerization🖼🧊📄§2026-03-102039-10-08031
12570978Methods and compositions for macrophage polarization🖼🧊📄§2026-03-102042-11-04031
12571000Diaphragm-specific nucleic acid regulatory elements and methods and use thereof🖼🧊📄§2026-03-102044-01-19031
12571002Gene therapies for lysosomal disorders🖼🧊📄§2026-03-102041-07-07031